NCT04094675View on ClinicalTrials.gov

Sirolimus for Cowden Syndrome With Colon Polyposis

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 16, 2019

Primary Completion Date

February 1, 2025

Study Completion Date

June 5, 2025

Conditions
PTEN Gene MutationPTEN Hamartoma Tumor SyndromePTEN Hamartoma SyndromeCowden SyndromeBannayan SyndromeBannayan Zonana SyndromePolyposis
Interventions
DRUG

Sirolimus

Use of sirolimus 2 mg by mouth daily for 1 year

Trial Locations (1)

43210

The Ohio State University Wexner Medical Center, Columbus

Sponsors

Collaborators (2)

PTEN Research
Pfizer
All Listed Sponsors
collaborator

PTEN Research

UNKNOWN

collaborator

Pfizer

INDUSTRY

lead

Ohio State University

OTHER